Spatz Medical, Inc. is a global leader in developing and marketing Spatz3, the world's first and only adjustable gastric balloon for the treatment of obesity. With a presence in over 60 markets and a vast patient base exceeding 150,000, Spatz3 introduces a unique adjustability feature. This enables doctors to tailor the volume of the balloon to address key challenges of traditional gastric balloons for improved weight loss. The Spatz adjustable gastric balloon has achieved outstanding weight loss results and an impressive 84% success rate, as demonstrated in clinical trials (Lancet) and real-world applications. Spatz3 is approved for use in adults with obesity. Learn more > https://www.spatzmedical.com/